Aptorum Group Ltd — Investor Relations & Filings
Aptorum Group Ltd. is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics to address unmet medical needs. The company's research and development pipeline targets a range of therapeutic areas, including orphan oncology, infectious diseases, and metabolic diseases. Key projects include SACT-1, a repurposed drug candidate for neuroblastoma, and ALS-4, an anti-virulence, non-bactericidal therapeutic for infections caused by Staphylococcus aureus. Additionally, the company is developing its RPIDD (Rapid Pathogen Identification and Detection Diagnostics) platform, a liquid biopsy-based technology for rapidly identifying and detecting pathogens.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 20-F - Aptorum Group Ltd (0001734005) (Filer) | 2026-03-27 | English | |
| 6-K Filing | 2026-02-06 | English | |
| S-4/A Filing | 2026-01-21 | English | |
| REGISTRATION STATEMENT | 2026-01-16 | English | |
| PROSPECTUS SUPPLEMENT | 2025-12-05 | English | |
| AMENDMENT NO. 1 TO FORM 6-K | 2025-12-05 | English |
Browse filings by year
9 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
4 filings
| |||||
| 33065447 | 20-F - Aptorum Group Ltd (0001734005) (Filer) | 2026-03-27 | English | ||
| 31520173 | 6-K Filing | 2026-02-06 | English | ||
| 31520178 | S-4/A Filing | 2026-01-21 | English | ||
| 13097379 | REGISTRATION STATEMENT | 2026-01-16 | English | ||
|
2025
11 filings
| |||||
| 13097380 | PROSPECTUS SUPPLEMENT | 2025-12-05 | English | ||
| 13097381 | AMENDMENT NO. 1 TO FORM 6-K | 2025-12-05 | English | ||
| 13097382 | Regulatory Filings 2025 | 2025-12-04 | English | ||
| 13097383 | DEL AM | 2025-11-18 | English | ||
| 13097384 | REGISTRATION STATEMENT | 2025-11-17 | English | ||
| 13097385 | REPORT OF FOREIGN PRIVATE ISSUER | 2025-10-16 | English | ||
| 13097386 | REPORT OF FOREIGN PRIVATE ISSUER | 2025-10-15 | English | ||
| 13097387 | PROSPECTUS SUPPLEMENT | 2025-10-14 | English | ||
| 13097388 | REPORT OF FOREIGN PRIVATE ISSUER | 2025-10-08 | English | ||
| 13097390 | REGISTRATION STATEMENT | 2025-10-06 | English | ||
| 13097389 | REPORT OF FOREIGN PRIVATE ISSUER | 2025-10-03 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
MAIA Biotechnology, Inc.
Clinical-stage immuno-oncology company developing telomere-…
|
MAIA | US | Manufacturing |
|
Mainz BioMed N.V.
A molecular genetics diagnostics company developing tests f…
|
MYNZ | NL | Manufacturing |
|
Makers Laboratories Ltd.
Manufactures and markets generic pharmaceuticals across div…
|
506919 | IN | Manufacturing |
|
Mangalam Drugs and Organics Ltd.
Produces APIs and intermediates with a focus on anti-malari…
|
MANGALAM | IN | Manufacturing |
|
Mankind Pharma Limited
Develops, manufactures, and markets pharmaceutical and cons…
|
MANKIND | IN | Manufacturing |
|
MANNKIND CORP
Biopharmaceutical firm developing inhaled therapies for car…
|
MNKD | US | Manufacturing |
|
MARAVAI LIFESCIENCES HOLDINGS, INC.
Life sciences company providing nucleic acid production and…
|
MRVI | US | Manufacturing |
|
Marinomed Biotech AG
Develops treatments for viral infectious diseases and immun…
|
MARI | AT | Manufacturing |
|
Marker Therapeutics, Inc.
Clinical-stage immuno-oncology company developing T cell-ba…
|
MRKR | US | Manufacturing |
|
Marksans Pharma Ltd.
Develops and manufactures generic pharmaceutical formulatio…
|
MARKSANS | IN | Manufacturing |
Aptorum Group Ltd via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35125/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35125 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35125 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35125 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35125}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Aptorum Group Ltd (id: 35125)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.